ϳԹȺ

Overactive bladder drug linked to depression


Thursday, 06 April, 2017

A recent international study published in found that women who received as part of treatment for overactive bladder were 38% more likely to be diagnosed with depressive disorder within the next 3 years than those who did not receive antimuscarinics.

“This population-based retrospective cohort study found that use of antimuscarinics was associated with subsequent depressive disorder in women with overactive bladder,” said Li-Ting Kao, senior author of study.

Although antimuscarinics can significantly depress bladder contractions and improve symptoms by blocking muscarinic receptors, studies have found that several unwanted side effects frequently occur when patients with an overactive bladder receive the drugs.

The (including memory loss) of antimuscarinic drugs in elderly patients are well established. One theory for the increased rate of side effects in elderly people is the increased blood-brain barrier permeability that can occur with advanced age and certain comorbidities may facilitate antimuscarinic access to the central nervous system.

Related News

Frances Rice appointed ACN Chief Nursing Officer

Frances Rice has been appointed the Australian College of Nursing's Chief Nursing Officer, a...

APNA is searching for its next CEO

As part of a planned transition from longtime CEO Ken Griffin, the Australian Primary Health Care...

NSWNMA: Proposed workers comp changes a "cruel blow"

The NSW Nurses and Midwives' Association has called proposed changes to the NSW workers...



Content from other channels on our network


  • All content Copyright © 2025 ϳԹȺ-Farrow Pty Ltd